|
Sep 9
|
CRL Stock May Benefit From New Neuroscience Research Collaboration
|
|
Sep 6
|
Why Is Charles River (CRL) Down 5.3% Since Last Earnings Report?
|
|
Sep 6
|
Higher Interest Environment Negatively Impacted Charles River Laboratories (CRL)
|
|
Sep 4
|
Charles River and Insightec Announce Strategic Collaboration to Advance Therapeutic Development Utilizing Focused Ultrasound in Neuroscience
|
|
Sep 1
|
Calculating The Intrinsic Value Of Charles River Laboratories International, Inc. (NYSE:CRL)
|
|
Aug 28
|
Charles River Laboratories International (CRL) Fell Due to a More Cautious Funding Environment
|
|
Jul 30
|
Charles River Collaborates with Patient Advocacy Group, FOXG1 Research Foundation to Advance Rare Disease Gene Therapy Development
|
|
Jul 24
|
Here's How Charles River (CRL) is Placed Ahead of Q2 Earnings
|
|
Jul 24
|
Charles River Laboratories and Autobahn Labs Announce Collaborative Program to Accelerate Academic Drug Discovery
|
|
Jul 9
|
Charles River (CRL) Teams Up to Aid Stargardt's Disease Therapy
|
|
Jul 8
|
Charles River to Perform Plasmid Manufacturing for AAVantgarde
|
|
Jul 5
|
Charles River (CRL) Could be an Apt Pick Right Now: Here's Why
|
|
Jun 25
|
Charles River Laboratories Announces Strategic Lentiviral Vector Manufacturing Collaboration with Gates Institute at University of Colorado Anschutz Medical Campus
|
|
Jun 18
|
‘The CRO Sector Looks Appealing,’ Says Goldman Sachs — Here Are 2 Stocks to Consider
|
|
Jun 18
|
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
|
|
Jun 18
|
Charles River and Captain T Cell sign vector production agreement
|
|
Jun 17
|
Charles River and Captain T Cell Announce Plasmid DNA and Viral Vector Manufacturing Alliance for Gene-Modified Cell Therapy
|
|
May 30
|
Charles River Launches Viral Vector Tech Transfer Program to Safeguard Gene Therapy Development
|
|
May 30
|
Reasons to Hold Charles River (CRL) in Your Portfolio Now
|
|
May 24
|
Charles River (CRL) Banks on RMS Growth Amid Competition
|